Literature DB >> 31768350

Proinsulin-Secreting Neuroendocrine Tumors of the Pancreas: A Single-Centre Experience.

Andrey Germanovich Kriger1, Stanislav Valer'evich Berelavichus1, Ayrat Radikovich Kaldarov1, Vladimir Igorevich Panteleev1, David Semjonovich Gorin1, Rimma Sangaevna Dugarova1, Marina Yur'evna Yukina2.   

Abstract

BACKGROUND: Proinsulinoma is a neuroendocrine tumor (NET) of the pancreas that produces prohormone proinsulin. These tumors are very rare. In the literature, they are most often presented in the form of case reports.
MATERIALS AND METHODS: We studied 177 patients with NET of the pancreas who underwent surgical treatment in the A.V. Vishnevsky National Medical Research Centre of Surgery from January 2007 to December 2018.
RESULTS: Of 81 patients with organic hyperinsulinism caused by functioning NETs of the pancreas during the study period, 3 (3.7%) had a proinsulinoma; 2 were female; and 1 was male. None of them admitted to weight gain during this period, and their BMI was normal. All patients presented with Whipple's triad during the 72-h fast. Tumor-enucleating surgery was performed: one robot assisted, two laparotomies. A normal glucose level after treatment was achieved in all cases.
CONCLUSION: In cases where clinical hypoglycemia is present, but the serum insulin level is within the normal range or even decreased, proinsulinoma should be suspected. For now, surgical resection remains the only effective method of treatment. Further investigation of pro-insulinomas is needed.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Hyperinsulinism; Hypoglycemia; Neuroendocrine tumor; Pancreas; Proinsulinoma

Year:  2019        PMID: 31768350      PMCID: PMC6873051          DOI: 10.1159/000501455

Source DB:  PubMed          Journal:  Gastrointest Tumors        ISSN: 2296-3774


  18 in total

1.  Insulinoma with low circulating insulin levels: the diagnostic value of proinsulin measurements.

Authors:  R N Alsever; J P Roberts; J G Gerber; M E Mako; A H Rubenstein
Journal:  Ann Intern Med       Date:  1975-03       Impact factor: 25.391

Review 2.  Beta-cell adenomas without hyperinsulinemia with use of highly specific insulin radioimmunoassays: case report and review of literature.

Authors:  Francisco J Gómez-Pérez; Daniel Cuevas-Ramos; Paloma Almeda Valdés; Carlos A Aguilar-Salinas; Roopa Mehta; Juan A Rull
Journal:  Endocr Pract       Date:  2010 Jul-Aug       Impact factor: 3.443

3.  Histochemistry, ultrastructure and hormone content of human insulinomas.

Authors:  W Creutzfeldt; C Creutzfeldt; H Frerichs; N S Track; R Arnold
Journal:  Horm Metab Res       Date:  1976       Impact factor: 2.936

4.  Octreotide exacerbated fasting hypoglycaemia in a patient with a proinsulinoma; the glucostatic importance of pancreatic glucagon.

Authors:  R Gama; V Marks; J Wright; J D Teale
Journal:  Clin Endocrinol (Oxf)       Date:  1995-07       Impact factor: 3.478

5.  Proinsulin Expressing Neuroendocrine Tumors of the Pancreas: An Underrecognized Entity.

Authors:  Romulo Celli; Laura H Tang; Guoping Cai; Mollie Freedman-Weiss; Monica Colunga; Ronald R Salem; Sachin Majumdar; Dhanpat Jain
Journal:  Pancreas       Date:  2019-01       Impact factor: 3.327

6.  Proinsulin-secreting neuroendocrine tumor of the pancreas.

Authors:  A Piovesan; A Pia; G Visconti; M Terzolo; A Leone; G Magro; F Cesario; G Borretta
Journal:  J Endocrinol Invest       Date:  2003-08       Impact factor: 4.256

7.  Hypoglycemic Syndrome without Hyperinsulinemia. A Diagnostic Challenge.

Authors:  Belén Pérez-Pevida; Miguel Ángel Idoate; Sara Fernández-Landázuri; Nerea Varo; Javier Escalada
Journal:  Endocr Pathol       Date:  2016-03       Impact factor: 3.943

8.  Multiple proinsulin-secreting tumors of the pancreas treated by laparoscopic distal pancreatectomy and splenectomy.

Authors:  Gary Clark; Craig Sadur; Balaram Puligandla
Journal:  World J Surg       Date:  2009-03       Impact factor: 3.352

Review 9.  Sporadically occurring functional pancreatic endocrine tumors: review of recent literature.

Authors:  Steven B Goldin; Jason Aston; Monika M Wahi
Journal:  Curr Opin Oncol       Date:  2008-01       Impact factor: 3.645

Review 10.  Diagnosis and minimally invasive resection of an insulinoma: report of an unusual case and review of the literature.

Authors:  Bruce J Gutelius; Mary T Korytkowski; Sally E Carty; Giselle G Hamad
Journal:  Am Surg       Date:  2007-05       Impact factor: 0.688

View more
  1 in total

1.  Intraoperative selective arterial calcium injection test to confirm complete resection of a proinsulinoma.

Authors:  Akimasa Sakamoto; Kohei Ogawa; Miku Iwata; Chihiro Ito; Mikiya Shine; Takashi Matsui; Yusuke Nishi; Mio Uraoka; Takeshi Utsunomiya; Tomoyuki Nagaoka; Kei Tamura; Naotake Funamizu; Hitoshi Inoue; Katsunori Sakamoto; Mie Kurata; Yasutsugu Takada
Journal:  J Surg Case Rep       Date:  2022-07-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.